देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Febantel; Pyrantel embonate
Vetoquinol SA
QP52AF02
Febantel; Pyrantel embonate
15 / 5 milligram(s)/millilitre
Oral suspension
CAM: Companion Animal Medicine as defined in relevant national legislation
pyrantel
Authorised
2008-05-23
Health Products Regulatory Authority 16 October 2020 CRN009Z8S Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Drontal Oral Suspension for Puppies 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES Febantel 15.0 mg Pyrantel 5.0 mg (as pyrantel embonate 14.4mg) EXCIPIENTS: Sodium benzoate (E211) 2.05 mg Sodium propionate (E281) 2.05 mg Ponceau 4R (E124) 0.25 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral suspension. Pale red suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (puppies and young dogs up to one year of age) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of roundworm infections in puppies and young dogs up to one year of age caused by: Ascarids: _Toxocara canis_ _Toxascaris leonina_ Hookworms: _Ancylostoma caninum_ _Uncinaria stenocephala_ Whipworm: _Trichuris vulpis_ 4.3 CONTRAINDICATIONS Do not use simultaneously with compounds containing piperazine. See sections 4.7 and 4.8. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Parasite resistance to any particular class of anthelmintic may develop following frequent repeated use of an anthelmintic of that class. Health Products Regulatory Authority 16 October 2020 CRN009Z8S Page 2 of 4 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The safety of the product has not been assessed in puppies younger than 2 weeks and weighing less than 0.600 kg. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Wash hands after use. Avoid direct contact with the skin and eyes. In case of accidental spillage wash the affected area immediately with clean running water. OTHER PRECAUTIONS None 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) In very rare cases mild transient digestive tract signs (e.g., vomiting diarrhoea) may occur. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Do not use in pregnant and lactating bitches. 4.8 INTERACTION WITH OTHER MEDICINAL P पूरा दस्तावेज़ पढ़ें